These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8459622)

  • 21. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).
    Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C
    Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741
    [No Abstract]   [Full Text] [Related]  

  • 22. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.
    Garbe C; Ellwanger U; Tronnier M; Brocker EB; Orfanos CE
    Cancer; 2002 Apr; 94(8):2305-7. PubMed ID: 12001131
    [No Abstract]   [Full Text] [Related]  

  • 23. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
    Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF
    J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors predicting recurrence and survival in sentinel lymph node-positive melanoma patients.
    Murali R; Desilva C; Thompson JF; Scolyer RA
    Ann Surg; 2011 Jun; 253(6):1155-64. PubMed ID: 21412144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic variables for patients with stage III malignant melanoma.
    Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC
    Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous melanoma--retrospective study of a small series of patients.
    Metcalf JS; Hawk JC; Kreutner A
    J S C Med Assoc; 1981 Mar; 77(3):113-7. PubMed ID: 6938740
    [No Abstract]   [Full Text] [Related]  

  • 27. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F; Kurul S; Camlica H; Topuz E
    Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Melanoma in Tunisia: A clinical and histological study of 46 cases].
    El Euch D; Zaraa I; Driss M; Fourati M; Mokni M; Rahal K; Ben Rodhane K; Ben Osman A
    Ann Dermatol Venereol; 2010 May; 137(5):391-2. PubMed ID: 20470923
    [No Abstract]   [Full Text] [Related]  

  • 30. [The prognosis of patients with level V melanomas of the extremities].
    Krüger I; Ghussen F; Groth W
    Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors for lymph node metastasis in malignant melanoma].
    Mussack T; Waldner H; Kharraz-Tavakol A
    Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
    Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
    Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deeply invasive cutaneous malignant melanoma.
    Elias EG; Didolkar MS; Goel IP; Formeister JF; Valenzuela LZ; Pickren JL; Hebel JR
    Surg Gynecol Obstet; 1981 Jul; 153(1):67-70. PubMed ID: 7244978
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of elective lymph node excision in melanoma of the trunk].
    Zimmermann T; Buhr J; Kelm C; Padberg W
    Zentralbl Chir; 1996; 121(6):478-82. PubMed ID: 8767335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sentinel lymph node biopsy and incidence of recurrence].
    Hautarzt; 2006 Mar; 57(3):182. PubMed ID: 17429861
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignant melanoma. Prediction of metastasis and survival based on gross anatomic characteristics.
    Long RT
    J Med Assoc State Ala; 1979 Jul; 49(1):31-8. PubMed ID: 469435
    [No Abstract]   [Full Text] [Related]  

  • 38. Is sentinel node status predictive of overall survival in patients with melanoma?
    Carlson GW
    Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
    Huber R; Krüger I; Stützer H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998].
    Schnorf M; Helfenstein U; Blum A; Ellwanger U; Garbe C; Burg G; Dummer R
    Praxis (Bern 1994); 2001 Dec; 90(50):2193-8. PubMed ID: 11793837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.